Tags
- 2023
- AbbVie Inc.
- Amgen
- Artificial
- Artificial Intelligence
- Astex
- AstraZeneca
- Biogen
- Biophysics
- Biotechnology
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Challenges
- Chemistry
- Daniel Nomura
- David Baker
- Degradation
- Diego Drug
- Discovery!
- Drug
- Drug discovery
- Fragment-based lead discovery
- Genentech
- Johnson & Johnson
- Lead generation
- Medicinal chemistry
- Merck Serono
- Molecule
- Myers Squibb
- Novartis
- Opportunities
- Pfizer
- Pharmacy
- Proteolysis
- San Diego
- Serono
- Small molecule
- Ten-code
- Transcription factor
- University of California, Berkeley
- University of Washington